EUVIMEDEUVIMED entdecken
Multizentrische StudieBeobachtungsstudieOpen Access · CC BY-NC-ND 4.0

Prognostic Implications of Functional Tricuspid Regurgitation in Asymptomatic Degenerative Mitral Regurgitation

Christophe Tribouilloy, Yohann Bohbot, Benjamin Essayagh, Giovanni Benfari, Jeroen J Bax, Thierry Le Tourneau, Yan Topilsky, Clemence Antoine, Dan Rusinaru, Francesco Grigioni, Nina Ajmone Marsan, Aniek van Wijngaarden und 5 weitere

ESC Heart Failure · 01.08.2025 · 12 (4) · 2591-2596

DOI: 10.1002/ehf2.15278 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift ESC Heart Failure, online erschienen am 23.03.2025. Verfasst von Christophe Tribouilloy und 16 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Amiens University Hospital, Amiens, France. Hauptthemen laut MEDLINE: Mitral Valve, Mitral Valve Insufficiency, Registries, Tricuspid Valve Insufficiency. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 7 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims

Functional tricuspid regurgitation (FTR) associated with degenerative mitral regurgitation (DMR) accentuates the severity of heart failure and is a marker of poor prognosis. Little is known about FTR associated with asymptomatic DMR. Methods and results The study included 1249 asymptomatic patients with moderate or severe DMR from the Mitral Regurgitation International Database-Quantitative (MIDA-Q) registry (mean age 64 ± 15 years, 25% female). Despite the asymptomatic status, absent/trivial FTR was noted in only 42%, mild in 34.5%, moderate in 11%, and severe FTR in 12.5%. Patients with higher FTR grades were older and more often female and had higher EuroScore II, larger left atrial volumes, and more atrial fibrillation (all P < 0.05). Patients with moderate or severe FTR had comparable 5-year survival (64 ± 4% and 65 ± 4%) and lower than patients with no/trivial FTR(96 ± 1%, P < 0.001). After adjustment for key prognostic factors, including age, left ventricular dilatation and dysfunction, DMR severity, left atrial dilatation, and pulmonary hypertension, ≥moderate FTR remained a strong predictor of mortality (HR = 2.08 [1.17–3.72], P = 0.013). Sensitivity analysis showed stable impact of ≥moderate FTR among patients with/without pulmonary hypertension, in women and men and for any other subset. For patients who underwent mitral valve surgery, post-operative survival rates were similar between those with no/trivial FTR and those with ≥moderate or severe FTR (P = 0.76), suggesting that surgery could reduce the excess mortality related to preoperative FTR.

Conclusions

Among asymptomatic patients with significant DMR, ≥moderate FTR is frequent and independently associated with higher mortality, independently of traditional guideline-based risk factors. These findings suggest that ≥moderate FTR should lead to consideration of early mitral surgery to improve outcomes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Mitral ValveMitral Valve InsufficiencyRegistriesTricuspid Valve InsufficiencyAgedFemaleHumansMaleMiddle AgedAsymptomatic DiseasesEchocardiographyFollow-Up StudiesGlobal HealthPrognosisRetrospective StudiesRisk FactorsSeverity of Illness IndexSurvival Rate

Stichwörter der Autor:innen

Degenerative mitral regurgitationFunctional tricuspid regurgitationOutcomeSurgerySurvival

Autor:innen und Institutionen

  • Department of Cardiology, Amiens University Hospital, Amiens, France.
  • UR UPJV 7517, Jules Verne University of Picardie, Amiens, France.
  • Division of Cardiovascular Diseases, Mayo Clinic, Rochester, Minnesota, USA.
  • Department of Echocardiography, Cardio X Clinic, Cannes, France.
  • Department of Cardiology, Leiden University Medical Center, Leiden, The Netherlands.
  • Department of Cardiology, University of Nantes, Nantes, France.

Zitieren

APA

Tribouilloy, C., Bohbot, Y., Essayagh, B., Benfari, G., Bax, J. J., Le Tourneau, T., Topilsky, Y., Antoine, C., Rusinaru, D., Grigioni, F., Ajmone Marsan, N., van Wijngaarden, A., Hochstadt, A., Roussel, J. C., Thapa, P., Hector, M., & Enriquez-Sarano, M. (2025). Prognostic Implications of Functional Tricuspid Regurgitation in Asymptomatic Degenerative Mitral Regurgitation. ESC Heart Failure, 12(4), 2591-2596. https://doi.org/10.1002/ehf2.15278

Vancouver

Tribouilloy C, Bohbot Y, Essayagh B, Benfari G, Bax JJ, Le Tourneau T, et al. Prognostic Implications of Functional Tricuspid Regurgitation in Asymptomatic Degenerative Mitral Regurgitation. ESC Heart Failure. 2025;12(4):2591-2596. doi:10.1002/ehf2.15278

BibTeX
@article{Tribouilloy2025,
  author = {Tribouilloy, Christophe and Bohbot, Yohann and Essayagh, Benjamin and Benfari, Giovanni and Bax, Jeroen J and Le Tourneau, Thierry and Topilsky, Yan and Antoine, Clemence and Rusinaru, Dan and Grigioni, Francesco and Ajmone Marsan, Nina and van Wijngaarden, Aniek and Hochstadt, Aviram and Roussel, Jean Christian and Thapa, Prabin and Hector, Michelena and Enriquez-Sarano, Maurice},
  title = {Prognostic Implications of Functional Tricuspid Regurgitation in Asymptomatic Degenerative Mitral Regurgitation},
  journal = {ESC Heart Failure},
  year = {2025},
  volume = {12},
  number = {4},
  pages = {2591--2596},
  doi = {10.1002/ehf2.15278}
}
Kostenlos starten →